Literature DB >> 35666520

Association of Aortic Stiffness and Pressure Pulsatility With Global Amyloid-β and Regional Tau Burden Among Framingham Heart Study Participants Without Dementia.

Leroy L Cooper1, Adrienne O'Donnell2,3, Alexa S Beiser2,3,4, Emma G Thibault5, Justin S Sanchez5, Emelia J Benjamin3,6,7,8,9, Naomi M Hamburg7,8, Ramachandran S Vasan3,6,7,8,9, Martin G Larson2,3, Keith A Johnson5,10, Gary F Mitchell11, Sudha Seshadri3,12.   

Abstract

Importance: Aortic stiffness is associated with clinical hallmarks of Alzheimer disease and related dementias and could be a modifiable target for disease prevention. Objective: To assess associations of aortic stiffness and pressure pulsatility with global amyloid-β plaques and regional tau burden in the brain of middle-aged and older adults without dementia. Design, Setting, and Participants: The sample for this cross-sectional study was drawn from the Framingham Heart Study Third Generation Cohort at examination 3 (N = 3171; 2016-2019), of whom 3092 successfully underwent comprehensive hemodynamic evaluations. In a supplemental visit (2015-2021), a subset of 270 participants without dementia who represented the spectrum of vascular risk also underwent positron emission tomography. Thirteen participants were excluded for missing covariate data. The final sample size was 257 participants. Exposures: Three measures of aortic stiffness and pressure pulsatility (carotid-femoral pulse wave velocity, central pulse pressure [CPP], and forward wave amplitude [FWA]) were evaluated using arterial tonometry. Main Outcomes and Measures: Global amyloid-β plaques and regional tau were assessed using 11C-Pittsburgh compound B and 18F-flortaucipir positron emission tomography tracers, respectively.
Results: The mean (SD) age of the 257 participants was 54 (8) years, and 126 were women (49%). All participants were White Western European race. In multivariable models, higher CPP (β per SD = 0.17; 95% CI, 0.00-0.35; P = .045) and FWA (β per SD = 0.16; 95% CI, 0.00-0.31; P = .04) were associated with greater entorhinal tau burden. In similar models, higher CPP (β per SD = 0.19; 95% CI, 0.02-0.36; P = .03) and FWA (β per SD = 0.17; 95% CI, 0.01-0.32; P = .03) were associated with greater rhinal tau burden. Aortic stiffness and pressure pulsatility measures were not associated with amygdala, inferior temporal, precuneus tau burden, or global amyloid-β plaques. Associations for entorhinal and rhinal tau outcomes were more prominent in older participants (≥60 years). For example, higher levels of all aortic stiffness and pressure pulsatility measures (β per SD = 0.40-0.92; P = .001-.02) were associated with higher entorhinal tau burden among older but not younger participants in stratified analyses. Conclusions and Relevance: In this cross-sectional study, abnormal central vascular hemodynamics were associated with higher tau burden in specific brain regions. Findings suggest that aortic stiffness, which is potentially modifiable, may be a probable independent target for prevention of tau-related pathologies.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35666520      PMCID: PMC9171656          DOI: 10.1001/jamaneurol.2022.1261

Source DB:  PubMed          Journal:  JAMA Neurol        ISSN: 2168-6149            Impact factor:   29.907


  63 in total

1.  Arterial stiffness, cognitive decline, and risk of dementia: the Rotterdam study.

Authors:  Mariëlle M F Poels; Marieke van Oijen; Francesco U S Mattace-Raso; Albert Hofman; Peter J Koudstaal; Jacqueline C M Witteman; Monique M B Breteler
Journal:  Stroke       Date:  2007-02-01       Impact factor: 7.914

2.  In vivo cortical spreading pattern of tau and amyloid in the Alzheimer disease spectrum.

Authors:  Hanna Cho; Jae Yong Choi; Mi Song Hwang; You Jin Kim; Hye Mi Lee; Hye Sun Lee; Jae Hoon Lee; Young Hoon Ryu; Myung Sik Lee; Chul Hyoung Lyoo
Journal:  Ann Neurol       Date:  2016-07-08       Impact factor: 10.422

3.  Decreased clearance of CNS beta-amyloid in Alzheimer's disease.

Authors:  Kwasi G Mawuenyega; Wendy Sigurdson; Vitaliy Ovod; Ling Munsell; Tom Kasten; John C Morris; Kevin E Yarasheski; Randall J Bateman
Journal:  Science       Date:  2010-12-09       Impact factor: 47.728

Review 4.  Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association.

Authors:  Philip B Gorelick; Angelo Scuteri; Sandra E Black; Charles Decarli; Steven M Greenberg; Costantino Iadecola; Lenore J Launer; Stephane Laurent; Oscar L Lopez; David Nyenhuis; Ronald C Petersen; Julie A Schneider; Christophe Tzourio; Donna K Arnett; David A Bennett; Helena C Chui; Randall T Higashida; Ruth Lindquist; Peter M Nilsson; Gustavo C Roman; Frank W Sellke; Sudha Seshadri
Journal:  Stroke       Date:  2011-07-21       Impact factor: 7.914

5.  Low-density lipoprotein receptor overexpression enhances the rate of brain-to-blood Aβ clearance in a mouse model of β-amyloidosis.

Authors:  Joseph M Castellano; Rashid Deane; Andrew J Gottesdiener; Philip B Verghese; Floy R Stewart; Tim West; Andrew C Paoletti; Tristan R Kasper; Ronald B DeMattos; Berislav V Zlokovic; David M Holtzman
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-27       Impact factor: 11.205

6.  An investigation of coronary heart disease in families. The Framingham offspring study.

Authors:  W B Kannel; M Feinleib; P M McNamara; R J Garrison; W P Castelli
Journal:  Am J Epidemiol       Date:  1979-09       Impact factor: 4.897

7.  Association of white matter hyperintensity volume with decreased cognitive functioning: the Framingham Heart Study.

Authors:  Rhoda Au; Joseph M Massaro; Philip A Wolf; Megan E Young; Alexa Beiser; Sudha Seshadri; Ralph B D'Agostino; Charles DeCarli
Journal:  Arch Neurol       Date:  2006-02

Review 8.  Biomarkers for tau pathology.

Authors:  Michael Schöll; Anne Maass; Niklas Mattsson; Nicholas J Ashton; Kaj Blennow; Henrik Zetterberg; William Jagust
Journal:  Mol Cell Neurosci       Date:  2018-12-07       Impact factor: 4.314

9.  The cortical origin and initial spread of medial temporal tauopathy in Alzheimer's disease assessed with positron emission tomography.

Authors:  Justin S Sanchez; J Alex Becker; Heidi I L Jacobs; Bernard J Hanseeuw; Shu Jiang; Aaron P Schultz; Michael J Properzi; Samantha R Katz; Alexa Beiser; Claudia L Satizabal; Adrienne O'Donnell; Charles DeCarli; Ron Killiany; Georges El Fakhri; Marc D Normandin; Teresa Gómez-Isla; Yakeel T Quiroz; Dorene M Rentz; Reisa A Sperling; Sudha Seshadri; Jean Augustinack; Julie C Price; Keith A Johnson
Journal:  Sci Transl Med       Date:  2021-01-20       Impact factor: 17.956

10.  Effect of APOE ε4 genotype on amyloid-β and tau accumulation in Alzheimer's disease.

Authors:  Min Seok Baek; Hanna Cho; Hye Sun Lee; Jae Hoon Lee; Young Hoon Ryu; Chul Hyoung Lyoo
Journal:  Alzheimers Res Ther       Date:  2020-10-31       Impact factor: 6.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.